文献速递眼底病与葡萄膜炎

抗VEGF治疗渗出性AMD中1型CNV的早期OCTA改变

Early OCT angiography changes of type 1 CNV in exudative AMD treated with anti-VEGF.
PubMed 文献 · Br J Ophthalmol · 2018-03-22

连续纳入16只眼(11眼接受阿柏西普、5眼接受雷珠单抗)的1型脉络膜新生血管(CNV)患眼,在抗VEGF治疗前及治疗后48小时行OCT血管成像(OCTA)检查。治疗后CNV平均面积和色素上皮脱离均显著缩小(p=0.0004和p=0.0007),细CNV血管密度在75%(12眼)下降,粗CNV血管密度在66.7%(10眼)保持稳定;作者认为OCTA可无创、可重复地分析1型CNV的早期重塑。

要点

  • 16眼1型CNV抗VEGF治疗后48小时OCTA示CNV面积与色素上皮脱离显著缩小。
  • 细CNV血管密度在75%(12眼)下降,粗CNV血管密度在66.7%(10眼)保持稳定。
  • OCT检查的操作者间可重复性良好,所有测量组内相关系数>0.65。

核心结论

  • 治疗后1型CNV网络的早期重塑可能可通过OCTA无创且可重复地分析。
  • 脉络膜灌注受损、脉络膜血流空虚信号及CNV周围区域可能在治疗期间发生变化。

研究设计与样本

  • 连续纳入接受玻璃体腔注射抗VEGF治疗的1型CNV患者。
  • 所有患者在抗VEGF治疗前及治疗后48小时行OCTA检查。
  • 评估黄斑区血管与形态学定量及定性改变。
  • 共纳入16只眼,其中11眼接受阿柏西普治疗、5眼接受雷珠单抗治疗。

主要发现

  • 治疗后CNV平均面积显著缩小(p=0.0004)。
  • 治疗后色素上皮脱离显著缩小(p=0.0007)。
  • 囊样黄斑水肿(4眼)在所有病例中均减轻。
  • 神经视网膜脱离(13眼)在85%的病例(11眼)中减轻。
  • 细CNV血管密度在75%(12眼)下降,粗CNV血管密度在66.7%(10眼)保持稳定。

关键数值与推荐

  • OCT检查的操作者间可重复性对所有测量均良好,组内相关系数>0.65。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS: To investigate, with optical coherence tomography angiography (OCTA), short-term changes of type 1 choroidal neovascularisation (CNV), secondary to exudative age-related macular degeneration, after anti-vascular endothelial growth factor (VEGF) treatment. METHODS: Patients affected by type 1 CNV treated with intravitreal anti-VEGF were consecutively enrolled. All patients underwent OCTA examination before and 48 hours after anti-VEGF treatment. Quantitative and qualitative vascular and morphological macular changes were evaluated. RESULTS: Sixteen eyes were included (11 treated with aflibercept and 5 with ranibizumab). Both CNV mean area and pigment epithelium detachment significantly reduced (p=0.0004 and p=0.0007, respectively) after treatment. Cystoid macular oedema (four eyes) decreased in all cases. Neuroretinal detachment (13 eyes) decreased in 85% of cases (11 eyes). Fine CNV vessels density decreased in 75% (12 eyes), whereas larger CNV vessels density remained stable in 66.7% (10 eyes), choroidal flow void signal (7 eyes at baseline) increased in 42.9% (3 eyes) of them and remained stable in 57.1% (4 eyes). Interoperator reproducibility for OCT examination was good for all measurements (intraclass correlation coefficient>0.65). CONCLUSION: Early remodelling of type 1 CNV network after treatment may be non-invasively and reproducibly analysed by means of OCTA. Choroidal perfusion impairment, choroidal flow void signal, surrounding CNV may change during treatment.

来源:Br J Ophthalmol,查看原文。版权归原作者所有。

引用

  1. Pilotto E, Frizziero L, Daniele AR, et al. Early OCT angiography changes of type 1 CNV in exudative AMD treated with anti-VEGF. Br J Ophthalmol. 2018. PMID: 29567794. doi:10.1136/bjophthalmol-2017-311752

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。